RASGRP1/APTX Ratio Strongly Correlates with Clinical Response and Survival in AML Patients Treated with Tipifarnib-Bortezomib Combination.
| Image |  |
|---|---|
| Description | scholarly article |
| Author/s |
author: Pier Paolo Piccaluga |
| Publication date | November 20, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |